Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Am J Physiol Cell Physiol ; 320(1): C1-C14, 2021 01 01.
Article in English | MEDLINE | ID: mdl-33085497

ABSTRACT

One of the major roles of the intracardiac nervous system (ICNS) is to act as the final site of signal integration for efferent information destined for the myocardium to enable local control of heart rate and rhythm. Multiple subtypes of neurons exist in the ICNS where they are organized into clusters termed ganglionated plexi (GP). The majority of cells in the ICNS are actually glial cells; however, despite this, ICNS glial cells have received little attention to date. In the central nervous system, where glial cell function has been widely studied, glia are no longer viewed simply as supportive cells but rather have been shown to play an active role in modulating neuronal excitability and synaptic plasticity. Pioneering studies have demonstrated that in addition to glia within the brain stem, glial cells within multiple autonomic ganglia in the peripheral nervous system, including the ICNS, can also act to modulate cardiovascular function. Clinically, patients with atrial fibrillation (AF) undergoing catheter ablation show high plasma levels of S100B, a protein produced by cardiac glial cells, correlated with decreased AF recurrence. Interestingly, S100B also alters GP neuron excitability and neurite outgrowth in the ICNS. These studies highlight the importance of understanding how glial cells can affect the heart by modulating GP neuron activity or synaptic inputs. Here, we review studies investigating glia both in the central and peripheral nervous systems to discuss the potential role of glia in controlling cardiac function in health and disease, paying particular attention to the glial cells of the ICNS.


Subject(s)
Atrial Fibrillation/metabolism , Central Nervous System/metabolism , Ganglia, Autonomic/metabolism , Heart/innervation , Neuroglia/metabolism , Neuronal Plasticity , S100 Calcium Binding Protein beta Subunit/metabolism , Synaptic Transmission , Action Potentials , Animals , Atrial Fibrillation/pathology , Atrial Fibrillation/physiopathology , Central Nervous System/pathology , Central Nervous System/physiopathology , Ganglia, Autonomic/pathology , Ganglia, Autonomic/physiopathology , Heart Rate , Humans , Neuroglia/pathology , Neuronal Outgrowth , Phenotype
2.
Cereb Cortex ; 27(6): 3437-3448, 2017 06 01.
Article in English | MEDLINE | ID: mdl-28334103

ABSTRACT

Neuronal pentraxin 1 (NPTX1) has been implicated in Alzheimer's disease, being present in and around dystrophic neurons in plaques, affecting glutamatergic transmission postsynaptically and mediating effects of amyloidß. Here, we confirm the presence of NPTX1 around plaques in postmortem Alzheimer's disease brain and report that acutely applied human NPTX1 increases paired-pulse ratio at mouse CA3-CA1 hippocampal synapses, indicating a decrease in glutamate release. In contrast, chronic exposure to NPTX1, NPTX2, or NPTX receptor decreases paired-pulse ratio, mimicking some of the earliest changes in mice expressing familial Alzheimer's disease genes. The peripheral pentraxin, serum amyloid P component (SAP), causes similar synaptic effects to NPTX1. The presence of SAP on amyloid plaques in Alzheimer's disease confirms that it can enter the brain. We show that SAP and neuronal pentraxins can interact and that SAP can enter the brain if the blood-brain barrier is compromised, suggesting that peripheral pentraxins could affect central synaptic transmission via this interaction, especially in the event of blood-brain barrier breakdown.


Subject(s)
Blood-Brain Barrier/physiopathology , C-Reactive Protein/metabolism , Glutamic Acid/metabolism , Hippocampus/physiology , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Aged, 80 and over , Alzheimer Disease/pathology , Animals , Animals, Newborn , Blood-Brain Barrier/pathology , C-Reactive Protein/genetics , C-Reactive Protein/pharmacology , Evoked Potentials/drug effects , Evoked Potentials/physiology , Female , GABA Antagonists/pharmacology , HEK293 Cells , Hippocampus/drug effects , Hippocampus/metabolism , Hippocampus/pathology , Humans , Lipopolysaccharides/pharmacology , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Middle Aged , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/pharmacology , Neurons/drug effects , Pyridazines/pharmacology , Serum Amyloid P-Component/pharmacology , Synapses/drug effects , Synapses/genetics , Synapses/metabolism
3.
Elife ; 102021 10 25.
Article in English | MEDLINE | ID: mdl-34693906

ABSTRACT

Experience-dependent plasticity is a key feature of brain synapses for which neuronal N-Methyl-D-Aspartate receptors (NMDARs) play a major role, from developmental circuit refinement to learning and memory. Astrocytes also express NMDARs, although their exact function has remained controversial. Here, we identify in mouse hippocampus, a circuit function for GluN2C NMDAR, a subtype highly expressed in astrocytes, in layer-specific tuning of synaptic strengths in CA1 pyramidal neurons. Interfering with astrocyte NMDAR or GluN2C NMDAR activity reduces the range of presynaptic strength distribution specifically in the stratum radiatum inputs without an appreciable change in the mean presynaptic strength. Mathematical modeling shows that narrowing of the width of presynaptic release probability distribution compromises the expression of long-term synaptic plasticity. Our findings suggest a novel feedback signaling system that uses astrocyte GluN2C NMDARs to adjust basal synaptic weight distribution of Schaffer collateral inputs, which in turn impacts computations performed by the CA1 pyramidal neuron.


Subject(s)
CA1 Region, Hippocampal/physiology , Neuronal Plasticity/physiology , Pyramidal Cells/physiology , Receptors, N-Methyl-D-Aspartate/genetics , Animals , Mice , Receptors, N-Methyl-D-Aspartate/metabolism
4.
PLoS One ; 15(6): e0230465, 2020.
Article in English | MEDLINE | ID: mdl-32559219

ABSTRACT

The slow afterhyperpolarising current, sIAHP, is a Ca2+-dependent current that plays an important role in the late phase of spike frequency adaptation. sIAHP is activated by voltage-gated Ca2+ channels, while the contribution of calcium from ryanodine-sensitive intracellular stores, released by calcium-induced calcium release (CICR), is controversial in hippocampal pyramidal neurons. Three types of ryanodine receptors (RyR1-3) are expressed in the hippocampus, with RyR3 showing a predominant expression in CA1 neurons. We investigated the specific role of CICR, and particularly of its RyR3-mediated component, in the regulation of the sIAHP amplitude and time course, and the activity-dependent potentiation of the sIAHP in rat and mouse CA1 pyramidal neurons. Here we report that enhancement of CICR by caffeine led to an increase in sIAHP amplitude, while inhibition of CICR by ryanodine caused a small, but significant reduction of sIAHP. Inhibition of ryanodine-sensitive Ca2+ stores by ryanodine or depletion by the SERCA pump inhibitor cyclopiazonic acid caused a substantial attenuation in the sIAHP activity-dependent potentiation in both rat and mouse CA1 pyramidal neurons. Neurons from mice lacking RyR3 receptors exhibited a sIAHP with features undistinguishable from wild-type neurons, which was similarly reduced by ryanodine. However, the lack of RyR3 receptors led to a faster and reduced activity-dependent potentiation of sIAHP. We conclude that ryanodine receptor-mediated CICR contributes both to the amplitude of the sIAHP at steady state and its activity-dependent potentiation in rat and mouse hippocampal pyramidal neurons. In particular, we show that RyR3 receptors play an essential and specific role in shaping the activity-dependent potentiation of the sIAHP. The modulation of activity-dependent potentiation of sIAHP by RyR3-mediated CICR contributes to plasticity of intrinsic neuronal excitability and is likely to play a critical role in higher cognitive functions, such as learning and memory.


Subject(s)
Action Potentials/drug effects , Calcium/metabolism , Calcium/pharmacology , Hippocampus/cytology , Pyramidal Cells/cytology , Pyramidal Cells/drug effects , Ryanodine Receptor Calcium Release Channel/metabolism , Animals , Hippocampus/drug effects , Kinetics , Mice , Pyramidal Cells/metabolism , Rats
5.
Front Neural Circuits ; 13: 21, 2019.
Article in English | MEDLINE | ID: mdl-31001092

ABSTRACT

In mammalian neurons, small conductance calcium-activated potassium channels (SK channels) are activated by calcium influx and contribute to the afterhyperpolarization (AHP) that follows action potentials. Three types of SK channel, SK1, SK2 and SK3 are recognized and encoded by separate genes that are widely expressed in overlapping distributions in the mammalian brain. Expression of the rat genes, rSK2 and rSK3 generates functional ion channels that traffic to the membrane as homomeric and heteromeric complexes. However, rSK1 is not trafficked to the plasma membrane, appears not to form functional channels, and the role of rSK1 in neurons is not clear. Here, we show that rSK1 co-assembles with rSK2. rSK1 is not trafficked to the membrane but is retained in a cytoplasmic compartment. When rSK2 is present, heteromeric rSK1-rSK2 channels are also retained in the cytosolic compartment, reducing the total SK channel content on the plasma membrane. Thus, rSK1 appears to act as chaperone for rSK2 channels and expression of rSK1 may control the level of functional SK current in rat neurons.


Subject(s)
Hippocampus/metabolism , Neurons/metabolism , Small-Conductance Calcium-Activated Potassium Channels/metabolism , Animals , Membrane Potentials/physiology , Protein Transport/physiology , Rats , Rats, Wistar
6.
Neuronal Signal ; 3(1): NS20180066, 2019 03.
Article in English | MEDLINE | ID: mdl-32269831

ABSTRACT

Cholinergic basal forebrain (cBF) neurons are defined by their expression of the p75 neurotrophin receptor (p75NTR) and tropomyosin-related kinase (Trk) neurotrophin receptors in addition to cholinergic markers. It is known that the neurotrophins, particularly nerve growth factor (NGF), mediate cholinergic neuronal development and maintenance. However, the role of neurotrophin signalling in regulating adult cBF function is less clear, although in dementia, trophic signalling is reduced and p75NTR mediates neurodegeneration of cBF neurons. Here we review the current understanding of how cBF neurons are regulated by neurotrophins which activate p75NTR and TrkA, B or C to influence the critical role that these neurons play in normal cortical function, particularly higher order cognition. Specifically, we describe the current evidence that neurotrophins regulate the development of basal forebrain neurons and their role in maintaining and modifying mature basal forebrain synaptic and cortical microcircuit connectivity. Understanding the role neurotrophin signalling plays in regulating the precision of cholinergic connectivity will contribute to the understanding of normal cognitive processes and will likely provide additional ideas for designing improved therapies for the treatment of neurological disease in which cholinergic dysfunction has been demonstrated.

7.
Nat Commun ; 9(1): 3195, 2018 08 10.
Article in English | MEDLINE | ID: mdl-30097576

ABSTRACT

Cerebellar ataxias are severe neurodegenerative disorders with an early onset and progressive and inexorable course of the disease. Here, we report a single point mutation in the gene encoding Elongator complex subunit 6 causing Purkinje neuron degeneration and an ataxia-like phenotype in the mutant wobbly mouse. This mutation destabilizes the complex and compromises its function in translation regulation, leading to protein misfolding, proteotoxic stress, and eventual neuronal death. In addition, we show that substantial microgliosis is triggered by the NLRP3 inflammasome pathway in the cerebellum and that blocking NLRP3 function in vivo significantly delays neuronal degeneration and the onset of ataxia in mutant animals. Our data provide a mechanistic insight into the pathophysiology of a cerebellar ataxia caused by an Elongator mutation, substantiating the increasing body of evidence that alterations of this complex are broadly implicated in the onset of a number of diverse neurological disorders.


Subject(s)
Ataxia/genetics , Behavior, Animal , Histone Acetyltransferases/genetics , Mutation/genetics , Nerve Degeneration/genetics , Animals , Ataxia/complications , Base Sequence , Caspase 1/metabolism , Female , Furans , Gliosis/pathology , Heterocyclic Compounds, 4 or More Rings/pharmacology , Histone Acetyltransferases/metabolism , Indenes , Inflammasomes/metabolism , Inflammation/pathology , Male , Mice, Inbred C57BL , Mice, Neurologic Mutants , Mice, Transgenic , Microglia/drug effects , Microglia/pathology , Models, Molecular , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Nerve Degeneration/complications , Phenotype , Protein Aggregates/drug effects , Protein Folding/drug effects , Protein Stability/drug effects , Purkinje Cells/pathology , Sulfonamides , Sulfones/pharmacology , Vacuoles/drug effects , Vacuoles/metabolism , Vacuoles/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL